Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.
| 11 Jan 2022 | |
| Alumnae News |
Melanie, who is based in the US, is Senior Vice President and Chief Development Officer at Moderna and led clinical trials to develop one of the world’s first COVID vaccines.
She said at the time: “We are trying to save the world and it’s a very exciting way to spend your day.” She was heartened by the scientific community’s response to fighting the pandemic. “Every day I’m really full of hope. Just the way we have come together as an industry. We are sharing our data, we’re working so collaboratively. It’s just the most extraordinary experience to be a part of. So I’m very, very hopeful and incredibly proud of what we are doing.”
The company is currently working on an Omicron-specific booster shot, which will be ready by late 2022. Its scientists are also exploring ways of using the mRNA technology that helped Covid-19 vaccines succeed to develop a universal flu vaccine with higher efficacy rates than those currently available.
Melanie is due to visit LEH in March to give the Goswell Lecture to current pupils.
Sky’s the Limit: LEH Alumna Sasha Nash Becomes First Woman to Lead the Red Arrows! More...
Alumna Celia Birchall designed the outfit worn by Jasmine Mitchell in her Great British Bake Off finale win, marking a p… More...
Zoe Mountstephen, Class of 1987, strengthens community through All Dressed Up, providing free prom dresses to students i… More...
Harriet Taylor, Class of 2021, former national champion & now Newcastle University rower, has launched a British Rowing … More...
Join us as we celebrate the season together and kick off the holidays in true LEH style! More...
